Record Information |
---|
Version | 1.0 |
---|
Created at | 2020-03-18 23:26:07 UTC |
---|
Updated at | 2022-12-13 23:36:22 UTC |
---|
CannabisDB ID | CDB000136 |
---|
Secondary Accession Numbers | Not Available |
---|
Cannabis Compound Identification |
---|
Common Name | L-Valine |
---|
Description | Valine, abbreviated as Val or V, one of 20 proteinogenic amino acids, is a non-polar amino acid with the chemical formula HO2CCH(NH2)CH(CH3)2. Valine is an essential amino acid that humans do not synthesize and must acquire from diet, usually from protein sources. Along with leucine and isoleucine, valine is a branched-chain amino acid (BCAA), an amino acid whose carbon structure is marked by a branch point. These three amino acids are critical to human life and are particularly involved in stress, energy and muscle metabolism. BCAA supplementation as therapy, both oral and intravenous, in human health and disease holds great promise. Despite their structural similarities, the branched amino acids have different metabolic routes, with valine going solely to carbohydrates, leucine solely to fats and isoleucine to both. The different metabolism accounts for different requirements for these essential amino acids in humans: 12 mg/kg, 14 mg/kg and 16 mg/kg of valine, leucine, and isoleucine, respectively. Furthermore, these amino acids have different deficiency symptoms. Valine deficiency is marked by neurological defects in the brain, while isoleucine deficiency is marked by muscle tremors. Many types of inborn errors of BCAA metabolism exist and are marked by various abnormalities. The most common form is the maple syrup urine disease, marked by a sweet urinary odor. Other abnormalities are associated with a wide range of symptoms, such as mental retardation, ataxia, hypoglycemia, spinal muscle atrophy, rash, vomiting and excessive muscle movement. Most forms of BCAA metabolism errors are corrected by dietary restriction of BCAA and at least one form is correctable by supplementation with 10 mg of biotin daily. BCAA are decreased in patients with liver disease, such as hepatitis, hepatic coma, cirrhosis, extrahepatic biliary atresia or portacaval shunt; aromatic amino acids (AAA) tyrosine, tryptophan and phenylalanine, as well as methionine are increased in these conditions. Valine has been established as a useful supplemental therapy for an ailing liver. All the BCAA probably compete with AAA for absorption into the brain. Supplemental BCAA with vitamin B6 and zinc help normalize the BCAA:AAA ratio. In sickle-cell disease, the hydrophobic amino acid valine replaces the hydrophilic amino acid glutamic acid in beta-globin, causing it to misfold. The sickle cell hemoglobin is thus prone to aggregation. Hypervalinemia is another example of an inborn error of metabolism involving valine, not the other BCAA. It is caused by a deficiency in the valine transaminase gene (PMID: 6067402 ). As with most amino acids, L-valine is also found in Cannabis plants (PMID: 6991645 ). |
---|
Structure | |
---|
Synonyms | Value | Source |
---|
(2S)-2-Amino-3-methylbutanoic acid | ChEBI | (S)-Valine | ChEBI | 2-Amino-3-methylbutyric acid | ChEBI | L-(+)-alpha-Aminoisovaleric acid | ChEBI | L-alpha-Amino-beta-methylbutyric acid | ChEBI | L-Valin | ChEBI | V | ChEBI | Val | ChEBI | VALINE | ChEBI | (2S)-2-Amino-3-methylbutanoate | Generator | 2-Amino-3-methylbutyrate | Generator | L-(+)-a-Aminoisovalerate | Generator | L-(+)-a-Aminoisovaleric acid | Generator | L-(+)-alpha-Aminoisovalerate | Generator | L-(+)-Α-aminoisovalerate | Generator | L-(+)-Α-aminoisovaleric acid | Generator | L-a-Amino-b-methylbutyrate | Generator | L-a-Amino-b-methylbutyric acid | Generator | L-alpha-Amino-beta-methylbutyrate | Generator | L-Α-amino-β-methylbutyrate | Generator | L-Α-amino-β-methylbutyric acid | Generator | (S)-2-Amino-3-methyl-butanoate | HMDB | (S)-2-Amino-3-methyl-butanoic acid | HMDB | (S)-2-Amino-3-methylbutanoate | HMDB | (S)-2-Amino-3-methylbutanoic acid | HMDB | (S)-2-Amino-3-methylbutyrate | HMDB | (S)-2-Amino-3-methylbutyric acid | HMDB | (S)-a-Amino-b-methylbutyrate | HMDB | (S)-a-Amino-b-methylbutyric acid | HMDB | (S)-alpha-Amino-beta-methylbutyrate | HMDB | (S)-alpha-Amino-beta-methylbutyric acid | HMDB | 2-Amino-3-methylbutanoate | HMDB | 2-Amino-3-methylbutanoic acid | HMDB | L Valine | HMDB |
|
---|
Chemical Formula | C5H11NO2 |
---|
Average Molecular Weight | 117.15 |
---|
Monoisotopic Molecular Weight | 117.079 |
---|
IUPAC Name | (2S)-2-amino-3-methylbutanoic acid |
---|
Traditional Name | L-valine |
---|
CAS Registry Number | 72-18-4 |
---|
SMILES | CC(C)[C@H](N)C(O)=O |
---|
InChI Identifier | InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1 |
---|
InChI Key | KZSNJWFQEVHDMF-BYPYZUCNSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Valine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Valine or derivatives
- Alpha-amino acid
- L-alpha-amino acid
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty acid
- Fatty acyl
- Amino acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organic oxide
- Organopnictogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Organic oxygen compound
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
|
Physiological effect | Health effect: |
---|
Disposition | Route of exposure: Source: Biological location: |
---|
Role | Industrial application: Biological role: |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 295 - 300 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 58.5 mg/mL | Not Available | logP | -2.26 | HANSCH,C ET AL. (1995) |
|
---|
Predicted Properties | [] |
---|
Spectra |
---|
EI-MS/GC-MS | Type | Description | Splash Key | View |
---|
EI-MS | Mass Spectrum (Electron Ionization) | splash10-05fr-9000000000-5d10fb7acd70b2f43368 | 2018-05-25 | View Spectrum | GC-MS | L-Valine, 2 TMS, GC-MS Spectrum | splash10-0006-0910000000-23bfcf2795f71f458bda | Spectrum | GC-MS | L-Valine, 2 TMS, GC-MS Spectrum | splash10-0006-0920000000-7892bb9d4d9afcc23410 | Spectrum | GC-MS | L-Valine, 2 TMS, GC-MS Spectrum | splash10-0006-0910000000-f2491152816b9c5dc7ed | Spectrum | GC-MS | L-Valine, 1 TMS, GC-MS Spectrum | splash10-0znj-1900000000-7c976d7c11a402db399f | Spectrum | GC-MS | L-Valine, 2 TMS, GC-MS Spectrum | splash10-00dl-8910000000-78e8ee971ad7298c23cd | Spectrum | GC-MS | L-Valine, 1 TMS, GC-MS Spectrum | splash10-00di-9200000000-805e6724e5181af78c81 | Spectrum | GC-MS | L-Valine, 2 TMS, GC-MS Spectrum | splash10-0006-0910000000-a212771a5ea868139d5a | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-059t-0900000000-7b8e4e98ac9158bf26d9 | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-0006-0910000000-9079324093be9a14d47a | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-0006-0910000000-23bfcf2795f71f458bda | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-0006-0920000000-7892bb9d4d9afcc23410 | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-0006-0910000000-f2491152816b9c5dc7ed | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-0znj-1900000000-7c976d7c11a402db399f | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-000i-2920000000-1628d46d5520c5f20de8 | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-00dl-8910000000-78e8ee971ad7298c23cd | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-00di-9200000000-805e6724e5181af78c81 | Spectrum | GC-MS | L-Valine, non-derivatized, GC-MS Spectrum | splash10-0006-0910000000-a212771a5ea868139d5a | Spectrum | Predicted GC-MS | L-Valine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | splash10-00dl-9000000000-602d1e01bc7567493e4c | Spectrum | Predicted GC-MS | L-Valine, 1 TMS, Predicted GC-MS Spectrum - 70eV, Positive | splash10-00dl-9500000000-a758682a7aafbd0d553e | Spectrum | Predicted GC-MS | L-Valine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | L-Valine, non-derivatized, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | L-Valine, TMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | L-Valine, TBDMS_1_1, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum | Predicted GC-MS | L-Valine, TBDMS_1_2, Predicted GC-MS Spectrum - 70eV, Positive | Not Available | Spectrum |
|
---|
MS/MS | Type | Description | Splash Key | View |
---|
MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated) | splash10-00di-9000000000-67498a3295a1fe788c4b | 2012-07-24 | View Spectrum | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated) | splash10-0a4i-9000000000-fb359f44fcf1b83ee14d | 2012-07-24 | View Spectrum | MS/MS | LC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated) | splash10-0a4i-9000000000-8e5f620c04615765a062 | 2012-07-24 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-014r-0900000000-619d80cc41221405e0bd | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-00di-9000000000-17ab53cec2e6b727c3e9 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-00di-9000000000-0dfbcc85d6423af91eda | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-014l-4900000000-c50d79ba3a5013bcf29f | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-0uxr-0900000000-67a7784963ec75cecaa0 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-00di-9000000000-4569516f23d8a712b434 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-001i-0900000000-d928cac1226f19b8edc3 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive | splash10-0udi-0900000000-34059351f2cbd94a8acc | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative | splash10-014i-0900000000-a36d8d68a6705027415f | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative | splash10-014i-0900000000-1a5d8f4c1b293de18fed | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative | splash10-014i-0900000000-b410df2c18dfc8ab7165 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive | splash10-0gi0-6900000000-c87ff036e3a5d15b7670 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive | splash10-00di-9000000000-561b3b28fa82e0b10658 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive | splash10-05fr-9000000000-11e7c0a3d5cf8e4dedfe | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive | splash10-0a4i-9000000000-6a6f8cd9629b0f09469c | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive | splash10-0a4i-9000000000-4518f691bbda5739c0f1 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - CE-ESI-TOF (CE-system connected to 6210 Time-of-Flight MS, Agilent) , Positive | splash10-014i-0900000000-a931cfc8207edac33775 | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive | splash10-00di-9000000000-430332b13b8c6368136b | 2012-08-31 | View Spectrum | MS/MS | LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative | splash10-014i-0900000000-ffb286a8ae38a0a3e6d2 | 2012-08-31 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00xr-9500000000-bb54662a5fd1dd142d90 | 2016-09-12 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-00di-9000000000-1f7d9c10db4226a383c1 | 2016-09-12 | View Spectrum | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-05fu-9000000000-f6d7e45bb3f3436e5eb7 | 2016-09-12 | View Spectrum |
|
---|
NMR | Type | Description | | View |
---|
1D NMR | 13C NMR Spectrum (1D, 125 MHz, H2O, experimental) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, D2O, experimental) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | | Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | | Spectrum | 2D NMR | [1H, 1H]-TOCSY. Unexported temporarily by An Chi on Oct 15, 2021 until json or nmrML file is generated. 2D NMR Spectrum (experimental) | | Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | | Spectrum |
|
---|
Pathways |
---|
Pathways | Name | SMPDB/Pathwhiz | KEGG | Valine, Leucine and Isoleucine Degradation | | | Propanoate Metabolism | | | Transcription/Translation | Not Available | Not Available | Beta-Ketothiolase Deficiency | | Not Available | 2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency | | Not Available |
|
---|
Protein Targets |
---|
Enzymes | |
Propionyl-CoA carboxylase beta chain, mitochondrial | PCCB | 3q21-q22 | P05166 | details | Catechol O-methyltransferase | COMT | 22q11.21 | P21964 | details | Branched-chain-amino-acid aminotransferase, cytosolic | BCAT1 | 12p12.1 | P54687 | details | Branched-chain-amino-acid aminotransferase, mitochondrial | BCAT2 | 19q13 | O15382 | details | Valine--tRNA ligase | VARS | 6p21.3 | P26640 | details | Valine--tRNA ligase, mitochondrial | VARS2 | 6p21.33 | Q5ST30 | details |
|
---|
Transporters | |
---|
Metal Bindings | |
---|
Receptors | Not Available |
---|
Transcriptional Factors | Not Available |
---|
Concentrations Data |
---|
| |
Alien Dawg | Detected and Quantified | 0.537 mg/g dry wt | | details | Gabriola | Detected and Quantified | 0.334 mg/g dry wt | | details | Island Honey | Detected and Quantified | 0.422 mg/g dry wt | | details | Quadra | Detected and Quantified | 0.439 mg/g dry wt | | details | Sensi Star | Detected and Quantified | 0.198 mg/g dry wt | | details | Tangerine Dream | Detected and Quantified | 0.172 mg/g dry wt | | details |
|
---|
External Links |
---|
HMDB ID | HMDB0000883 |
---|
DrugBank ID | DB00161 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FoodDB ID | FDB004905 |
---|
KNApSAcK ID | C00001398 |
---|
Chemspider ID | 6050 |
---|
KEGG Compound ID | C00183 |
---|
BioCyc ID | VAL |
---|
BiGG ID | 34167 |
---|
Wikipedia Link | L-valine |
---|
METLIN ID | 5842 |
---|
PubChem Compound | 6287 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 16414 |
---|
References |
---|
General References | - Turner CE, Elsohly MA, Boeren EG: Constituents of Cannabis sativa L. XVII. A review of the natural constituents. J Nat Prod. 1980 Mar-Apr;43(2):169-234. doi: 10.1021/np50008a001. [PubMed:6991645 ]
- Dancis J, Hutzler J, Tada K, Wada Y, Morikawa T, Arakawa T: Hypervalinemia. A defect in valine transamination. Pediatrics. 1967 Jun;39(6):813-7. [PubMed:6067402 ]
|
---|